Montserat’s project is one of the 20 projects selected from among almost 1,000 proposals submitted to the call, which will receive a total of 2.7 million euros.
Emmanuelle Charpentier and Jennifer Doudna have been awarded the Nobel Prize in Chemistry 2020 for discovering a gene technology in Bioengineering: the CRISPR/Cas9 genetic scissors. The announcement marks the first time a science Nobel has been awarded to two women.
.
Under the name of “Modern approaches for developing antivirals against SARS-CoV 2” (MAD-CoV 2) the project focuses on the development and delivery of therapeutic tools for the current COVID-19 outbreak.
Now, Riccardo Levato, former researcher at IBEC, has been awarded with an ERC starting grant at UMC Utrecht to develop his project named “VOLUME-BIO”.
The holidays are over and it’s time to go back to work, also for our youngest and curious minds of the students that visit us every year. Despite the situation we are experiencing due to the coronavirus outbreak, at the Institute for Bioengineering of Catalonia (IBEC) we are making an effort to resume some of our outreach activities in person. In this sense, the IBEC laboratories have reopened the doors for the students participating in the “Bojos per la Bioenginyeria” and the “Batx2Lab” programs, adapting to this “new normality”.
The results will be translated into a device that will recreate the tumor environment from cancer cells derived from patients, as well as a new technology that will allow to visualize how physical forces affect the nuclei of metastatic cells.
In a recent paper led by Ulm University in Germany and co-authored and co-led by Demestre, researchers describe the effect of SHANK3 protein on muscle tissues of patients with autism disorder.
IBEC researchers Irene Marco and Núria Torras, together with eight more female scientists, have won the programme “To the Mothers of Science” organized by The Barcelona Institute of Science and Technology (BIST), supporting them along the way to greater responsibility positions.
